2This chapter is relevant to all natural and legal persons to whom the short selling regulation applies, whether or not they are regulated by the FSA.

The purpose of this chapter is to provide guidance in relation to the FSA's functions under the short selling regulation.2

1The FSA is required by article 23 of the short selling regulation to consider whether to impose measures to prohibit or restrict short selling or otherwise limit transactions in a financial instrument on a trading venue where the price of that financial instrument on that trading venue has fallen significantly during a single trading day in relation to the closing price on that venue on the previous trading day. In fulfilling this obligation, the FSA will assess:

1. (1)

   whether the price fall is or may become disorderly; and, if so in either case,

2. (2)

   whether the imposition of measures to prohibit, restrict or limit transactions will prevent a further disorderly decline in the price of the financial instrument.

The FSA will assess whether the price fall in a financial instrument on a trading venue is or may become disorderly having regard to at least the following factors:

1. (1)

   whether there have been violent movements in the price of the particular financial instrument on a particular trading venue, including any sudden or significant movements in price of a financial instrument during the trading day;

2. (2)

   whether there is evidence of unusual or improper trading in the financial instrument on a particular trading venue which could indicate that there was pressure to set the price of the financial instrument at a level that would be considered abnormal for that financial instrument; and

3. (3)

   whether there are unsubstantiated rumours or dissemination of false or misleading information regarding the financial instrument.

The list above is not exhaustive and the FSA will consider such other factors as it considers appropriate.

The FSA may consider that the price fall in a financial instrument is not disorderly, for example, if the FSA considers that there is legitimate cause for a price fall in trading, such as the announcement of poor financial results.

The FSA will consider at least the following factors when assessing whether measures to prohibit or restrict short selling or otherwise limit transactions are necessary or likely to prevent a further disorderly decline in the price of the financial instrument:

1. (1)

   the volume of trading in that financial instrument on the trading venue as compared with the total trading volume in the financial instrument over at least that trading day; and

2. (2)

   whether the price of the financial instrument has stabilised after the significant fall in price.

The list above is not exhaustive and the FSA will consider such other factors as it considers appropriate.

Where the FSA imposes measures under article 23 of the short selling regulation it will normally specify that the measures will not apply to natural or legal persons who have satisfied the criteria to use the market maker exemption or the authorised primary dealer exemption and who are included on the list maintained and published by ESMA pursuant to article 17(13) of the short selling regulation.

1. (1)

   For the purposes of article 23(1)(b) of Commission Delegated Regulation (EU) No 918/2012 the FSA will convert the figure of EUR 0.50 into pounds sterling using the daily spot foreign exchange rate of Sterling to Euro of the Bank of England applicable at the end of the first business day of October 2012 rounded up to the nearest £0.01. The FSA will state this figure (the 'sterling figure') on its public website.

2. (2)

   The rate will be calculated on the same basis at the end of the first business day of October every subsequent year, unless the situation in (3) occurs in the intervening period, in which case the FSA will recalculate the sterling figure.

3. (3)

   The situation referred to in (2) is if the daily spot foreign exchange rate of the Bank of England of Sterling to Euro fluctuates for a period of 20 consecutive business days by more than 10% from the rate last used to calculate the sterling figure.

4. (4)

   If the situation in (3) occurs more than once in a year, the FSA will convert the figure of EUR 0.50 into pounds sterling using the daily spot foreign exchange rate of Sterling to Euro of the Bank of England applicable at the end of the 20th business day of the period referred to in (3).

The FSA will treat the FTSE 100 index as the main national equity index of the Member State for the purposes of article 6(4) of Commission Implementing Regulation (EU) No 827/2012 and article 4 of Commission Delegated Regulation (EU) No 826/2012 and article 23(1) of Commission Delegated Regulation (EU) No 918/2012, all subject to approval by European Parliament and Council.

Pursuant to the Financial Services and Markets Act 2000 (Short Selling) Regulations 2012 (SI 2012/2554), the FSA will direct how notifications to use the market maker exemption or the authorised primary dealer exemption shall be made. Such directions will be published on the FSA website and listed in FINMAR 2 Annex 1 G.

1. (1)

   If the FSA considers that a natural or legal person ('P') who has notified the FSA of his intention to use either the market maker exemption or the authorised primary dealer exemption does not satisfy the criteria to use the market maker exemption or the authorised primary dealer exemption, the FSA will send a letter to P setting out the reasons why it is minded to prohibit P from using the market maker exemption or the authorised primary dealer exemption.

2. (2)

   P will be given the opportunity to make written representations to the FSA concerning P's use of the market maker exemption or the authorised primary dealer exemption.

3. (3)

   The FSA will decide whether to prohibit P's use of either the market maker exemption or the authorised primary dealer exemption having regard to P's notification and any written representations made by P. The decision whether or not to prohibit the use by P of either the market maker exemption or the authorised primary dealer exemption will be made by senior staff members of the FSA who were not involved in the initial consideration of P's notification.

If P is not satisfied with the FSA's decision to prohibit P's use of the market maker exemption or the authorised primary dealer exemption, P may seek a review of the decision. This will be conducted by a group of at least three senior FSA staff. None of the group conducting the review will have been connected with the earlier decision taken in respect of P's use of the market maker exemption or the authorised primary dealer exemption. The review may take place after the expiry of the 30 day period in which the notification should be made under the short selling regulation, but within 3 months of the decision referred to in FINMAR 2.6.2 G (3).

This table belongs to FINMAR 2.6.1 G

[to follow]1